La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.

Identifieur interne : 003861 ( Main/Exploration ); précédent : 003860; suivant : 003862

Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.

Auteurs : P. Seeman [Canada] ; R. Corbett ; H H Van Tol

Source :

RBID : pubmed:9327943

English descriptors


PubMed: 9327943


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.</title>
<author>
<name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P" last="Seeman">P. Seeman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Pharmacology Department, University of Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Pharmacology Department, University of Toronto</wicri:regionArea>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Corbett, R" sort="Corbett, R" uniqKey="Corbett R" first="R" last="Corbett">R. Corbett</name>
</author>
<author>
<name sortKey="Van Tol, H H" sort="Van Tol, H H" uniqKey="Van Tol H" first="H H" last="Van Tol">H H Van Tol</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1998">1998</date>
<idno type="RBID">pubmed:9327943</idno>
<idno type="pmid">9327943</idno>
<idno type="wicri:Area/PubMed/Corpus">001786</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001786</idno>
<idno type="wicri:Area/PubMed/Curation">001786</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001786</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001786</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001786</idno>
<idno type="wicri:Area/Ncbi/Merge">002603</idno>
<idno type="wicri:Area/Ncbi/Curation">002603</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002603</idno>
<idno type="wicri:doubleKey">1054-3589:1998:Seeman P:dopamine:d:receptors</idno>
<idno type="wicri:Area/Main/Merge">003E72</idno>
<idno type="wicri:Area/Main/Curation">003861</idno>
<idno type="wicri:Area/Main/Exploration">003861</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.</title>
<author>
<name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P" last="Seeman">P. Seeman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Pharmacology Department, University of Toronto, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Pharmacology Department, University of Toronto</wicri:regionArea>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Corbett, R" sort="Corbett, R" uniqKey="Corbett R" first="R" last="Corbett">R. Corbett</name>
</author>
<author>
<name sortKey="Van Tol, H H" sort="Van Tol, H H" uniqKey="Van Tol H" first="H H" last="Van Tol">H H Van Tol</name>
</author>
</analytic>
<series>
<title level="j">Advances in pharmacology (San Diego, Calif.)</title>
<idno type="ISSN">1054-3589</idno>
<imprint>
<date when="1998" type="published">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antipsychotic Agents (adverse effects)</term>
<term>Clozapine (metabolism)</term>
<term>Dopamine (metabolism)</term>
<term>Dopamine D2 Receptor Antagonists</term>
<term>Humans</term>
<term>Muscarinic Antagonists</term>
<term>Parkinson Disease, Secondary (chemically induced)</term>
<term>Parkinson Disease, Secondary (prevention & control)</term>
<term>Radioligand Assay</term>
<term>Receptor, Serotonin, 5-HT2A</term>
<term>Receptors, Dopamine D2 (metabolism)</term>
<term>Receptors, Dopamine D4</term>
<term>Receptors, Muscarinic (metabolism)</term>
<term>Receptors, Serotonin (metabolism)</term>
<term>Serotonin Antagonists</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antipsychotic Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Clozapine</term>
<term>Dopamine</term>
<term>Receptors, Dopamine D2</term>
<term>Receptors, Muscarinic</term>
<term>Receptors, Serotonin</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Dopamine D2 Receptor Antagonists</term>
<term>Muscarinic Antagonists</term>
<term>Receptor, Serotonin, 5-HT2A</term>
<term>Receptors, Dopamine D4</term>
<term>Serotonin Antagonists</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en">
<term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Parkinson Disease, Secondary</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Radioligand Assay</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Ontario</li>
</region>
<settlement>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Corbett, R" sort="Corbett, R" uniqKey="Corbett R" first="R" last="Corbett">R. Corbett</name>
<name sortKey="Van Tol, H H" sort="Van Tol, H H" uniqKey="Van Tol H" first="H H" last="Van Tol">H H Van Tol</name>
</noCountry>
<country name="Canada">
<region name="Ontario">
<name sortKey="Seeman, P" sort="Seeman, P" uniqKey="Seeman P" first="P" last="Seeman">P. Seeman</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003861 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003861 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:9327943
   |texte=   Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:9327943" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022